| 1 |
Xu X, Jia L, Ma X, Li H, Sun C. Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity. Front Pharmacol 2021;12:792331. [PMID: 35095502 DOI: 10.3389/fphar.2021.792331] [Reference Citation Analysis]
|
| 2 |
Pan B, Wang Y, Wu C, Jia J, Huang C, Fang S, Liu L. A Mechanism of Action Study on Danggui Sini Decoction to Discover Its Therapeutic Effect on Gastric Cancer. Front Pharmacol 2020;11:592903. [PMID: 33505310 DOI: 10.3389/fphar.2020.592903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 3 |
Yin W, Xu J, Li C, Dai X, Wu T, Wen J. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression. Cell Biol Int 2020;44:1616-27. [PMID: 32239594 DOI: 10.1002/cbin.11354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Li C, Du X, Liu Y, Liu QQ, Zhi WB, Wang CL, Zhou J, Li Y, Zhang H. A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases. Evid Based Complement Alternat Med 2020;2020:5196302. [PMID: 32025235 DOI: 10.1155/2020/5196302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 5 |
Wang Y, Wu S, Yang C, Gao H, Yu H, Lu X, Yuan S. Construction and Analysis of circRNA-miRNA-mRNA Molecular Regulatory Networks During Herba Gelsemium elegans Intoxication. Front Pharmacol 2019;10:1217. [PMID: 31680981 DOI: 10.3389/fphar.2019.01217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 6 |
Chen Q, Lin W, Yin Z, Zou Y, Liang S, Ruan S, Chen P, Li S, Shu Q, Cheng B, Ling C. Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer. Evid Based Complement Alternat Med 2019;2019:9602935. [PMID: 31057657 DOI: 10.1155/2019/9602935] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 7 |
Miyata Y, Sakai H. Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies. Int J Mol Sci 2018;19:E3270. [PMID: 30347885 DOI: 10.3390/ijms19103270] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
|
